Happy Friday! The Fed announced yet another interest rate cut, and markets closed at an all-time high. But what really sent them soaring wasn’t the rate cut - it was this announcement by the Fed Chair. Plus, why the Fed may have to stop cutting rates sooner than it wanted.

Plus, check out today’s sponsor, a pioneering medical company out of Japan.

MARKET RECAP

Yesterday: Markets closed at record highs after Fed Chair Powell cut interest rates and said he isn’t going anywhere.

On Our Radar: Traders and investors are taking a brief break from the election and earnings today, as the Fed announces whether it’s cutting interest rates, and by how much.

TOP STORY

Wall Street Closes At Record Highs After Reassurance From Powell: Magnificent 7 Hit $17 Trillion, Treasury Yields Erase Post-Election Spike

The Fed cut interest rates yesterday and market surged yet again, closing at record highs. The “Magnificent 7” tech stocks did especially well. But it wasn’t the rate cut it self that sent stocks soaring.

Instead, it was this announcement by Fed Chair Powell.

SPONSORED CONTENT

SBC Medical Group (Nasdaq: SBC): “If We Become No. 1 In Asia, I Believe We Will Become No. 1 In The World”

Cosmetic surgery has become undetectable, setting off a trend in which everyone from celebrities to the more everyday global population is seeking treatments. SBC Medical Group (Nasdaq: SBC) is in the midst of a growth story being architected by CEO Yoshiyuki Aikawa. 

As a franchiser to aesthetic medical clinics around the world, SBC Medical currently enjoys a market leadership position in Japan, where it has its roots. The company is expanding both organically and through M&A, which has caused a Zacks research analyst to label the stock as severely undervalued, attaching a bullish $15.40 price target to shares. 

Mr.  Aikawa participated in a webcast to share more about the company’s performance as well as his vision for the future. Given the popularity of cosmetic surgery, the company believes it is well positioned for further strengthening of its balance sheet, including continued revenue and profit margin growth. Investors can catch a glimpse of all the stock has to offer here.

This is a paid ad. Please see 17b disclosure here for more information.

FIVE ZINGERS

No entry fee, no risk: You could win up to $30,000. Just sign up for Benzinga's paper trading competition and start making those trades.

Old Bills: Trump may have won the election, but Biden’s signature bills are still law. Here’s three stocks Goldman Sachs think will see major upside from the Inflation Reduction Act.

The Trump Trade: Tech stocks are getting all the headlines, but financial stocks are up a whopping 30% this year. Here’s why Trump’s win will keep them soaring.

What Tariffs Will Do: President-elect Trump has proposed replacing income taxes with tariffs - a tax on all goods entering the country. Here’s what experts say that will do to the economy.

A Beautiful Bounce: It may have started as a joke, but cryptocurrency Dogecoin has become a trader favorite - and is up 79% in just a month. And this rally has plenty of legs left.

ONE FOR THE ROAD

Fed's Interest Rate Cut Pace Expected To Slow: Economists Weigh Trump's White House Return

The Fed may have just lowered interest rates again, but experts are saying there’s not much more of that coming.

With yesterday’s cut, the Fed funds rate is now at 4.5% to 4.75%. Economists are expecting cuts to continue until we get to somewhere around 3% or 3.5%.

Here’s why the Fed will have to stop cutting rates sooner than previously planned.

SPONSORED CONTENT

Invest in a Portfolio That Consistently Beats the Market

Our “Perfect Stock” Portfolio features a curated selection of expert-picked stocks with proven track records, designed for steady growth. Access investments built to outperform the market today, right here.

BEFORE YOU GO

Were you forwarded this email? Click here to subscribe.

And be sure to check out our other newsletters:

Future Finance: Where fintech, crypto, and the future of finance collide. Future Finance is a perfect lunch read packed with quick bites for industry enthusiasts. Subscribe here.

Cannabis Daily: A must-read daily briefing for cannabis investors, operators, and enthusiasts. Join our list of industry veterans to jump start your morning. Subscribe here.

Real Estate Weekly: Ready to elevate your real estate game? This weekly newsletter provides actionable insights whether you are investing in REITs, owning property, or delving into the fast-growing world of fractional real estate. Subscribe here.

Advisor: Tailor-made for Financial Advisors, this weekly newsletter has industry-specific insights, analysis, and news. Subscribe here.